Embecta Corp. (EMBC)
5.99
+0.30
(+5.36%)
USD |
NASDAQ |
Oct 12, 16:00
5.985
0.00 (0.00%)
After-Hours: 20:00
Embecta Free Cash Flow (Quarterly) : 40.70M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 40.70M |
| March 31, 2026 | 30.60M |
| December 31, 2025 | 16.60M |
| September 30, 2025 | 76.70M |
| June 30, 2025 | 80.80M |
| March 31, 2025 | 31.70M |
| December 31, 2024 | -6.80M |
| September 30, 2024 | 26.60M |
| June 30, 2024 | -11.80M |
| March 31, 2024 | 20.90M |
| December 31, 2023 | -15.80M |
| Date | Value |
|---|---|
| September 30, 2023 | 20.40M |
| June 30, 2023 | -16.10M |
| March 31, 2023 | -18.80M |
| December 31, 2022 | 55.70M |
| September 30, 2022 | 49.40M |
| June 30, 2022 | 27.50M |
| March 31, 2022 | 176.80M |
| December 31, 2021 | 134.50M |
| September 30, 2021 | 72.10M |
| June 30, 2021 | 122.00M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Artivion, Inc. | -12.01M |
| Abbott Laboratories | 1.991B |
| AngioDynamics, Inc. | -18.48M |
| Alphatec Holdings, Inc. | -1.582M |
| AtriCure, Inc. | 18.43M |